Barrett Thornhill
🏛️ Revolving DoorFormer Government Positions:
Legislative Assistant, Sen. Mike Crapo (2003-2006); Legislative Assistant, Rep. Pat Toomey (2002-2003); Legislative Assistant, Rep. Charlie Norwood (2001-2002)
Legislative Assistant, Sen. Mike Crapo (2003-2006)
🤖
AI Overview
Barrett Thornhill has appeared in 1,444 federal lobbying filings at Forbes-tate, representing 50 clients. As a former government official, they bring insider expertise to their lobbying work — part of Washington's "revolving door." Active across 29 policy areas.
1,444
Total Filings
1
Firms
50
Clients
29
Issue Areas
Issue Areas
Filing History
| Year | Filings | Clients |
|---|---|---|
| 2020 | 273 | 33 |
| 2021 | 255 | 32 |
| 2022 | 245 | 28 |
| 2023 | 251 | 31 |
| 2024 | 218 | 26 |
| 2025 | 202 | 28 |
Firms
Forbes-tate1444 filings
Top Clients
Novartis, INC.145 filings
PHRMA114 filings
Genentech98 filings
Amgen USA, INC.88 filings
Lilly USA, LLC66 filings
Global Medical Response64 filings
Csl Behring59 filings
Vir Biotechnology, INC.57 filings
Ginkgo Bioworks45 filings
Lykos Therapeutics42 filings
Verde Technologies37 filings
Gilead Sciences, INC.34 filings
Bio-rad Laboratories33 filings
Horizon Therapeutics30 filings
Hcr Manorcare27 filings
Eyepoint Pharmaceuticals, INC.25 filings
Sarepta Therapeutics21 filings
Lundbeck LLC20 filings
Association of American Medical Colleges19 filings
Related Analysis
Related Investigations
The Revolving Door Exposed
How former government officials become the most powerful lobbyists.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Follow the Money
Tracking lobbying dollars through the financial system.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.